VIKING THERAPEUTICS INC's ticker is VKTX and the CUSIP is 92686J106. A total of 199 filers reported holding VIKING THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.47 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $64,804,725 | +23.1% | 1,222,500 | +90.4% | 0.01% | +22.2% |
Q1 2024 | $52,660,072 | +152.7% | 642,196 | -42.7% | 0.01% | +125.0% |
Q4 2023 | $20,841,060 | +216.6% | 1,119,885 | +88.3% | 0.00% | +300.0% |
Q3 2023 | $6,582,101 | -41.4% | 594,589 | -14.2% | 0.00% | -50.0% |
Q2 2023 | $11,231,293 | -22.5% | 692,862 | -20.4% | 0.00% | -50.0% |
Q1 2023 | $14,485,267 | +1833.0% | 869,986 | +991.3% | 0.00% | – |
Q4 2022 | $749,368 | +741848.5% | 79,720 | +115.3% | 0.00% | – |
Q3 2022 | $101 | -39.2% | 37,035 | -35.4% | 0.00% | – |
Q2 2022 | $166 | -100.0% | 57,357 | -78.0% | 0.00% | – |
Q1 2022 | $781,000 | +95.2% | 260,349 | +199.3% | 0.00% | – |
Q4 2021 | $400,000 | -54.7% | 86,997 | -38.1% | 0.00% | – |
Q3 2021 | $883,000 | -49.5% | 140,611 | -51.8% | 0.00% | – |
Q2 2021 | $1,749,000 | +464.2% | 291,981 | +495.4% | 0.00% | – |
Q1 2021 | $310,000 | -29.2% | 49,043 | -36.9% | 0.00% | – |
Q4 2020 | $438,000 | -88.0% | 77,770 | -87.6% | 0.00% | -100.0% |
Q3 2020 | $3,638,000 | -12.4% | 625,024 | +8.5% | 0.00% | 0.0% |
Q2 2020 | $4,154,000 | +967.9% | 576,154 | +592.6% | 0.00% | – |
Q1 2020 | $389,000 | -66.0% | 83,189 | -41.7% | 0.00% | – |
Q4 2019 | $1,145,000 | +74.3% | 142,755 | +49.4% | 0.00% | – |
Q3 2019 | $657,000 | +170.4% | 95,542 | +226.7% | 0.00% | – |
Q2 2019 | $243,000 | -62.5% | 29,244 | -55.1% | 0.00% | – |
Q1 2019 | $648,000 | -61.6% | 65,195 | -70.4% | 0.00% | -100.0% |
Q4 2018 | $1,687,000 | -7.5% | 220,448 | +110.5% | 0.00% | – |
Q3 2018 | $1,824,000 | +67.0% | 104,739 | -9.0% | 0.00% | – |
Q2 2018 | $1,092,000 | +18.2% | 115,096 | -45.6% | 0.00% | – |
Q1 2018 | $924,000 | +2540.0% | 211,429 | +623.1% | 0.00% | – |
Q4 2016 | $35,000 | -20.5% | 29,239 | +128.0% | 0.00% | – |
Q4 2015 | $44,000 | -58.9% | 12,826 | -29.8% | 0.00% | – |
Q3 2015 | $107,000 | -36.7% | 18,262 | -22.9% | 0.00% | – |
Q2 2015 | $169,000 | – | 23,694 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
APIS CAPITAL ADVISORS, LLC | 148,000 | $1,638,360 | 2.12% |
Sio Capital Management, LLC | 595,002 | $6,586,672 | 2.04% |
5AM Venture Management, LLC | 585,000 | $6,475,950 | 1.86% |
Artia Global Partners LP | 383,580 | $4,246,231 | 1.76% |
Integral Health Asset Management, LLC | 800,000 | $8,856,000 | 1.23% |
Boxer Capital, LLC | 2,000,000 | $22,140,000 | 1.18% |
DAFNA Capital Management LLC | 319,655 | $3,538,581 | 1.10% |
Affinity Asset Advisors, LLC | 332,600 | $3,681,882 | 1.04% |
MPM BioImpact LLC | 325,000 | $3,597,750 | 0.96% |
Affinity Asset Advisors, LLC | 300,000 | $3,321,000 | 0.93% |